X

Biotechnology

Rossari Biotech Ltd Q4FY24; 17% rise in Profits

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. Financial Results:…

Laurus Labs Ltd Q4 FY24 Earnings Conference Call Insights

Key highlights from Laurus Labs Ltd (LAURUSLABS) Q4 FY24 Earnings Concall R&D Progress Advanced several pipeline projects across offerings and…

Laurus Labs Ltd Q4FY24; 29% fall in Profits

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active…

Wockhardt Ltd Q3FY24; 0% rise in Revenue

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams…

Laurus Labs Ltd Q3FY24; 89% fall in Profits

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active…

Syngene International Ltd Q3FY24; 2% rise in Profits

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Laurus Labs Limited Q3 FY24 Earnings Conference Call Insights

Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY24 Earnings Concall Business Performance Gross margins remained resilient at over 52%…

Laurus Labs Limited Q2 FY24 Earnings Conference Call Insights

Key highlights from Laurus Labs Limited (LAURUSLABS) Q2 FY24 Earnings Concall Q2 FY24 Results Revenue declined 22% year-on-year to INR1,224…

Syngene International Ltd Q2FY24; 14% rise in Profits

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Wockhardt Ltd Q1FY24; 8% rise in Revenue

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams…

Shilpa Medicare Ltd Q1FY24; 50% fall in Profits

Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system,…

Panacea Biotec Q4FY23 Earnings Story

Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly…

Panacea Biotec Q4FY23; 8% Fall in Revenues

Panacea Biotec Ltd.’s revenue in Q4FY23 rose 13% to ₹ 12,557 crores. Consolidated Profit After Tax came at ₹ 4,320…

Laurus Labs Limited Q4 FY23 Earnings Conference Call Insights

https://youtu.be/5Vtl-XMN8qg Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding…

Laurus Labs Limited Q3 FY23 Earnings Conference Call Insights

Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY23 Earnings Concall Management Update: [00:03:57] LAURUSLABS said its strong results were…

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd (NSE: SYNGENE) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Syngene reported a 5% rise in its net profit for Q3FY23

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104…

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd  (NSE: SYNGENE) Q3 FY23 Earnings Concall dated January 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Shares of Biocon research arm soars as it reports 23% rise in its revenue

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104…

Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Transcript

Biocon Limited (NSE: BIOCON) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Saurabh Paliwal -- Head, Investor Relations…

Dishman Carbogen Amcis Ltd (DCAL) Q2 FY22 Earnings Concall Transcript

Dishman Carbogen Amcis Ltd (NSE: DCAL) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Arpit Vyas -- Global Managing Director…